Melvin Chiu, MD, MPH, has been appointed chair of the Department of Dermatology at the Keck School of Medicine of the University of Southern California, according to a university announcement.

The Keck School of Medicine, based in Los Angeles, operates one of the larger academic medical centers on the West Coast. The dermatology department sits within a multi-specialty academic practice that typically supports residency training, fellowship programs, and clinical research in medical, surgical, and pediatric dermatology.

What does the announcement confirm?

The university's communication identifies Chiu by two credentials: a medical doctorate and a Master of Public Health degree. Dual MD/MPH training in dermatology is uncommon and usually reflects an interest in epidemiology, health services research, public health dermatology, or community-based skin disease work alongside clinical practice.

The announcement did not include several details that typically accompany a chair-level appointment: a start date, a named professorship, the name of the prior chair, a public statement from Dr. Chiu, or any reference to faculty transitions.

What is the role of a dermatology chair?

A chair of dermatology at an academic medical center oversees three primary missions: clinical care, research, and education. Operationally, that means directing faculty recruitment, setting subspecialty clinic priorities, and shaping the department's participation in clinical trials for conditions such as psoriasis, atopic dermatitis, acne, hidradenitis suppurativa, and melanoma.

Chairs also influence the institution's relationships with industry partners, the National Institutes of Health, and disease-focused research consortia. Fellowship track design, residency curriculum, and the department's approach to emerging therapies — including new biologics and small molecules — often shift under new leadership.

Why does the public health credential matter?

Physicians who complete an MPH alongside an MD frequently concentrate their academic work on questions of access, cost, and population-level outcomes. In dermatology, that focus has grown in relevance as biologics, immunomodulators, and targeted therapies expand the cost and complexity of care. A chair with formal public health training may signal an institutional interest in health services research, disparities in skin disease outcomes, or community-based skin cancer screening.

An MPH credential does not by itself define a research agenda. The dermatology community will look for early evidence of Dr. Chiu's priorities in subsequent faculty announcements and departmental communications.

What details remain undisclosed?

At the time of writing, the following points had not been addressed in the public announcement:

• The effective date of the transition
• The identity of the outgoing chair
• Whether Dr. Chiu will continue an existing clinical practice
• Departmental priorities for the next academic cycle
• Any planned changes to residency or fellowship programming

What to watch next

Subsequent announcements typically clarify the pace and direction of a leadership change. The first signals are usually visible in faculty hiring decisions, conference programming, and the department's published research output over the next 12 to 24 months.

For referring clinicians and community dermatologists in the Los Angeles region, the most immediate operational interest is continuity of care, appointment access, and whether the existing specialty clinic structure will change. For the broader academic dermatology community, the appointment reflects continuing turnover in leadership at U.S. dermatology programs.

Derm Field will update this report as additional details are released by the Keck School of Medicine.